Cargando…

Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics

BACKGROUND: The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS: A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Acebo, Inés, Prado, Sara Rodríguez, De La Mora, Ángel, Puente, Roberto Zarrabeitia, de la Roza Varela, Beatriz, Dierssen-Sotos, Trinidad, Llorca, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322834/
https://www.ncbi.nlm.nih.gov/pubmed/32600370
http://dx.doi.org/10.1186/s13023-020-01433-5
_version_ 1783551716748165120
author Gómez-Acebo, Inés
Prado, Sara Rodríguez
De La Mora, Ángel
Puente, Roberto Zarrabeitia
de la Roza Varela, Beatriz
Dierssen-Sotos, Trinidad
Llorca, Javier
author_facet Gómez-Acebo, Inés
Prado, Sara Rodríguez
De La Mora, Ángel
Puente, Roberto Zarrabeitia
de la Roza Varela, Beatriz
Dierssen-Sotos, Trinidad
Llorca, Javier
author_sort Gómez-Acebo, Inés
collection PubMed
description BACKGROUND: The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS: A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit of Hospital de Sierrallana, a reference centre for Spanish patients with HHT. Odds ratios for several symptoms or characteristics of HHT and ocular lesions were estimated using logistic regression adjusting for age and sex. RESULTS: The ocular involvement was associated with being a carrier of a mutation for the ENG gene, that is, suffering from a type 1 HHT involvement (OR = 2.09; 95% CI [1.17–3.72]). p = 0.012). In contrast, patients with ocular lesions have less frequently mutated ACVRL1/ALK1 gene (OR = 0.52; 95% CI [0.30–3.88], p = 0.022). CONCLUSIONS: In conclusion, half of the patients with HHT in our study have ocular involvement. These eye lesions are associated with mutations in the ENG gene and ACVRL1/ALK1 gene. Thus, the ENG gene increases the risk of ocular lesions, while being a carrier of the mutated ACVRL1/ALK1 gene decreases said risk.
format Online
Article
Text
id pubmed-7322834
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73228342020-06-29 Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics Gómez-Acebo, Inés Prado, Sara Rodríguez De La Mora, Ángel Puente, Roberto Zarrabeitia de la Roza Varela, Beatriz Dierssen-Sotos, Trinidad Llorca, Javier Orphanet J Rare Dis Research BACKGROUND: The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS: A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit of Hospital de Sierrallana, a reference centre for Spanish patients with HHT. Odds ratios for several symptoms or characteristics of HHT and ocular lesions were estimated using logistic regression adjusting for age and sex. RESULTS: The ocular involvement was associated with being a carrier of a mutation for the ENG gene, that is, suffering from a type 1 HHT involvement (OR = 2.09; 95% CI [1.17–3.72]). p = 0.012). In contrast, patients with ocular lesions have less frequently mutated ACVRL1/ALK1 gene (OR = 0.52; 95% CI [0.30–3.88], p = 0.022). CONCLUSIONS: In conclusion, half of the patients with HHT in our study have ocular involvement. These eye lesions are associated with mutations in the ENG gene and ACVRL1/ALK1 gene. Thus, the ENG gene increases the risk of ocular lesions, while being a carrier of the mutated ACVRL1/ALK1 gene decreases said risk. BioMed Central 2020-06-29 /pmc/articles/PMC7322834/ /pubmed/32600370 http://dx.doi.org/10.1186/s13023-020-01433-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gómez-Acebo, Inés
Prado, Sara Rodríguez
De La Mora, Ángel
Puente, Roberto Zarrabeitia
de la Roza Varela, Beatriz
Dierssen-Sotos, Trinidad
Llorca, Javier
Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
title Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
title_full Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
title_fullStr Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
title_full_unstemmed Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
title_short Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
title_sort ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322834/
https://www.ncbi.nlm.nih.gov/pubmed/32600370
http://dx.doi.org/10.1186/s13023-020-01433-5
work_keys_str_mv AT gomezaceboines ocularlesionsinhereditaryhemorrhagictelangiectasiageneticsandclinicalcharacteristics
AT pradosararodriguez ocularlesionsinhereditaryhemorrhagictelangiectasiageneticsandclinicalcharacteristics
AT delamoraangel ocularlesionsinhereditaryhemorrhagictelangiectasiageneticsandclinicalcharacteristics
AT puenterobertozarrabeitia ocularlesionsinhereditaryhemorrhagictelangiectasiageneticsandclinicalcharacteristics
AT delarozavarelabeatriz ocularlesionsinhereditaryhemorrhagictelangiectasiageneticsandclinicalcharacteristics
AT dierssensotostrinidad ocularlesionsinhereditaryhemorrhagictelangiectasiageneticsandclinicalcharacteristics
AT llorcajavier ocularlesionsinhereditaryhemorrhagictelangiectasiageneticsandclinicalcharacteristics